Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,660 | 26,297 | 27,468 | 51,764 | 60,481 |
| Marketable Securities | 36,282 | 36,285 | 18,371 | N/A | N/A |
| Receivables | 2,129 | 3,267 | N/A | N/A | N/A |
| TOTAL | $77,270 | $66,958 | $46,452 | $52,828 | $61,179 |
| Non-Current Assets | |||||
| PPE Net | 118 | 184 | 235 | 468 | 334 |
| TOTAL | $118 | $184 | $235 | $468 | $334 |
| Total Assets | $77,387 | $67,141 | $46,687 | $53,296 | $61,513 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,536 | 966 | 1,444 | 2,330 | 580 |
| Accrued Expenses | 5,189 | 3,191 | 3,793 | 2,810 | 1,520 |
| TOTAL | $23,661 | $19,027 | $11,788 | $13,820 | $9,662 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,936 | 14,870 | 6,552 | 8,680 | 7,562 |
| TOTAL | $18,475 | $24,000 | $1,000 | $7,765 | $16,221 |
| Total Liabilities | $42,136 | $43,027 | $12,788 | $21,585 | $25,883 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,722 | 29,469 | 29,136 | 28,916 | 28,532 |
| Common Shares | 30 | 29 | 29 | 29 | 29 |
| Retained earnings | -127,165 | -131,831 | -112,521 | -114,480 | -109,219 |
| Other shareholders' equity | 15 | -4 | -9 | 0 | 0 |
| TOTAL | $35,251 | $24,115 | $33,899 | $31,711 | $35,630 |
| Total Liabilities And Equity | $77,387 | $67,141 | $46,687 | $53,296 | $61,513 |